NEWSROOM
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicine Will provide key regulatory and reimbursement support Will assist business development efforts and strategic partnerships Irvine, Calif., Jan. 8, 2025 - PRISM MediaWire - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, announces the appointment of Dr. Paul Billings as the company’s Consulting Chief Medical Officer. In this part-time role, he will support a...
SMC Entertainment Closes Acquisition of Boutique Investment Manager, Bateau Asset Management, Providing Entry to Australian and Southeast Asian Financial Services Markets
Bateau Asset Management brings to SMC Entertainment: Foundational acquisition into International Financial Services Sector Well-established client base of high-net-worth individuals Experienced global client services team based in Australia and Singapore Research and advisory capabilities complementary to SMC Entertainment’s Fintech platform BOCA RATON, Fla., January 8, 2025 - PRISM MediaWire - SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE), a Fintech incubator company...
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
Study of Vendaje® versus standard of care aims to show superior wound treatment, supporting market expansion POMPANO BEACH, Fla., January 8, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces the initiation of the BR-AM-DFU (BioREtain® Amniotic Membrane - Diabetic Foot Ulcers) clinical trial to evaluate Vendaje® versus...
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York, January 07, 2024 -PRISM MediaWire - PRISM MarketView has released an exclusive interview with Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, is addressing unmet...
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
Following the Closing of its 2024 Transactions, EzFill is Now Operating in Miami, West Palm Beach, Orlando, Tampa, Jacksonville, Los Angeles, San Francisco, Nashville, Detroit, Dallas, Houston, Austin, San Antonio, and Phoenix MIAMI, January 07, 2025 – EzFill Holdings, Inc. (NASDAQ: EZFL), a leading mobile fueling company, today announced the completion of its purchase of a fleet of trucks from Shell Retail and Convenience Operations LLC (“Shell”), a wholly owned subsidiary of Shell Oil...
Formation Minerals, Inc. Announces Entry Into $10,000,000 Equity Financing Agreement with GHS Investments, LLC
Jacksboro, TX, January 7, 2025 - PRISM MediaWire - Formation Minerals, Inc. (”Formation" or the "Company") (OTCQB: FOMI), a pure play oil and gas company based in Jacksboro, Texas, engaged in the acquisition and management of mineral and royalty interests in lower risk, onshore oil and gas properties within the major oil and gas plays in the United States, today announced that on December 31, 2024, the Company entered into an Equity Financing Agreement (the “Agreement”) with GHS Investments,...
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms eligibility for billing under current Local Coverage Determination (LCD) and Z-Code Up to 20% of patients will have detectable DSA within the first five years post kidney transplant, representing greater than 10,000 patients per year in the US.1 From time of onset of dnDSA, 24%...
Blaqclouds Provides Update on the Successful Soft Launch of ShopwithCrypto.io
Revolutionizing Crypto Spendability with Real-Time Gift Card Purchases ROBESONIA, Pa., Jan. 06, 2025 - PRISM MediaWire - Blaqclouds, Inc. (OTC: BCDS) is thrilled to announce the impressive results of the soft launch of ShopwithCrypto.io, a groundbreaking platform that brings real-world spendability to cryptocurrency holders. During this limited launch phase, the platform opened to 500 crypto enthusiasts, achieving remarkable metrics and showcasing its potential. Soft Launch Highlights: Initial...
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group
CEO Letter Published on OTCMarkets.com WEWAHITCHKA-PORT ST JOE, Fla., Jan. 06, 2025 - PRISM MediaWire - UAV Corp (OTC: UMAV) had an outstanding 2024, marked by groundbreaking innovations, strategic alliances, and significant advancements in key markets. Looking to 2025 we’re focused on securing $1.5 billion in contracts, unveiling innovations like the DART SA70-12, and expanding our state-of-the-art facilities, including the "SKY" hangar. With sustainability, innovation, and financial strength...
AmpliTech Group Announces Receipt of Notice of Allowance for Another Patent For Its LNA Technology
Hauppauge, NY, January 6, 2025 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued another Notice...